By application, the market is segmented into metabolic, oncology, gastrointestinal, neurological, cardiovascular and others. The metabolic segment dominated the peptide therapeutics market share in 2021, accounting owing to high prevalence of metabolic disorders and growing geriatric population susceptible to metabolic disorder. The oncology segment is expected to witness highest CAGR during the forecast period, owing to rise in cases of cancer globally and the presence of a strong product pipeline.
The peptide therapeutics market is estimated to reach $64.3 billion by 2031, growing at a CAGR of 6.8% from 2022 to 2031.
The peptide therapeutics market analysis is segmented by application, route of administration, distribution channel and region.